Send Inquiry

Request To Call Back

fosaprepitant dimeglumine

Get a Price/Quote

fosaprepitant dimeglumine Specification

Molecular Formula
C60H78F14N10O20P2

Place of Origin
China

Molecular Weight
1587.2414868 Grams (g)

Storage
Freezer

Other Names
Fosaprepitant dimeglumine;D-Glucitol, 1-deoxy-1-(methylamino)-, (3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4- morpholinyl)methyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl)phosphonate (2:1) (salt)

CAS No
265121-04-8

Grade
Medicine Grade

Usage
Fosaprepitant is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant.

Purity
99%min

Appearance
solid

Application
Pharmaceutical Industry

Form
Solid

fosaprepitant dimeglumine Trade Information

Minimum Order Quantity
1 Ton

FOB Port
Shanghai

Payment Terms
Letter of Credit (L/C), Paypal, Western Union, Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T)

Supply Ability
1000 Tons Per Week

Delivery Time
15 Days

Sample Available
Yes

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
foil/bag/bottle

Main Export Market(s)
Eastern Europe, Middle East, Western Europe, Africa, South America, Asia, Central America, North America, Australia

About fosaprepitant dimeglumine

Backed by rich industry experience, we are able to offer superior qualityfosaprepitant dimeglumine. Our qualified professionals precisely formulate these drugs from quality chemicals and other ingredients, sourced from the reliable vendors of the industry. The drugs we offer are quality examined by our expert members to ensure perfectfosaprepitant dimeglumine. We are able to deliver these products under a specific time-frame at market leading prices.

CAS NO.: 265121-04-8
Molecular Formula:C⁶⁰H⁷⁸F¹⁴N¹⁰O²⁰P²
Molecular Weight:1587.2414868

Trusted Intravenous Antiemetic Solution

Fosaprepitant dimeglumine offers a reliable means of managing chemotherapy-induced nausea and vomiting. As a solid, medicine-grade compound with over 99% purity, it is ideal for pharmaceutical applications. Designed for intravenous use, this drug transitions into aprepitant in the body, helping provide smooth and effective symptom control during oncology treatments. Its high standard ensures consistency for healthcare needs.

Optimized Pharmaceutical Quality and Storage

This product is formulated to meet the demands of the pharmaceutical industry, coming as a solid of precise molecular composition. Proper storage in a freezer setting ensures stability and preserves efficacy. Sourced from China, it is distributed by established industry players, allowing for prompt supply and consistent product quality worldwide.

FAQs of fosaprepitant dimeglumine:

Q: How is fosaprepitant dimeglumine administered?

A: Fosaprepitant dimeglumine is administered intravenously under professional supervision, typically as part of a regimen to prevent nausea and vomiting associated with chemotherapy treatments.

Q: What makes fosaprepitant dimeglumine a preferred antiemetic in the pharmaceutical industry?

A: Its high purity (99% min), reliable conversion to the active drug aprepitant, and effectiveness in managing chemotherapy-induced symptoms make fosaprepitant dimeglumine a preferred choice in pharmaceutical settings.

Q: When should fosaprepitant dimeglumine be used?

A: This medication is generally used before chemotherapy begins, as directed by a healthcare provider, to proactively manage and reduce the risk of nausea and vomiting during cancer treatments.

Q: Where is fosaprepitant dimeglumine manufactured and supplied from?

A: Fosaprepitant dimeglumine is manufactured in China and distributed worldwide through a network of exporters, distributors, suppliers, and traders in the pharmaceutical industry.

Q: What is the proper storage method for fosaprepitant dimeglumine?

A: To maintain its stability and potency, fosaprepitant dimeglumine should be stored in a freezer as specified by the manufacturers guidelines.

Q: What are the benefits of using fosaprepitant dimeglumine?

A: Fosaprepitant dimeglumine effectively transforms into aprepitant in the body, providing sustained control over nausea and vomiting, thus improving patient comfort and treatment outcomes during chemotherapy.

Q: Can you describe the process by which fosaprepitant dimeglumine works?

A: Once administered intravenously, fosaprepitant dimeglumine acts as a prodrug, quickly converting in the body to aprepitant, which then blocks neurokinin-1 (NK1) receptors to help prevent chemotherapy-induced nausea.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in Pharmaceutical Chemicals Category

Bimatoprost Chemical

Minimum Order Quantity : 1 Unit

Application : Pharmaceutical Industry

Grade : Medicine Grade

Usage : Bimatoprost (marketed in the US, Canada and Europe by Allergan, under the trade name Lumigan) is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes.

CAS No : 155206001

Form : Powder

Get a Price/Quote